Associate Professor of Medicine

Division of Hematology and Oncology

University of Pennsylvania Perelman School of Medicine

 

Dr. Vogl’s research focus is on clinical trials of novel therapies plasma cell malignancies and specifically myeloma, with an emphasis on translational Phase I and II trials. He is the Director of the Abramson Cancer Center Clinical Research Unit, overseeing the work of over 90 research nurses, research coordinators, regulatory coordinators and biospecimen coordinators, who together manage over 300 active cancer clinical trials. Dr. Vogl has published in several high-impact journals such as the Cancer Research Communications and Clinical Cancer Research.

Dan.Vogl@pennmedicine.upenn.edu